Prolong Pharmaceuticals' Series B Round

Prolong Pharmaceuticals raised a round of funding on October 14, 2010.

Prolong Pharmaceuticals is developing products to treat several diseases and their debilitating comorbidities associated with reduced quality of life, increased medical cost, and significant mortality…

Articles about Prolong Pharmaceuticals' Series B Round: